Back to RecallTracker
Health Canada Health products

ARZERRA (ofatumumab) - Recommendations to Screen, Monitor and to Manage Hepatitis B Virus Reactivation - For Health Professionals

Issued January 27, 2014
Issue
Hazard description
Product safety